Other Name(s):

Abhaya, Amandier Indien, Amandier Tropical, Arale, Arjan des Indes, Arjuna, Axjun Argun, Badamier, Badamier chebule, Badamier Géant, Baheda, Bahera, Bala Harade, Balera, Behada, Beleric Myrobalan, Belleric Myrobalan, Belliric Myrobalan, Bhibitaki, Bibhitak, Bibitaki, Black myrobalan, Carambole Marron, Chebulic Myrobalan, Chebulische, Gall nut, Gallnut, Hara, Harad, Harada, Harade, Haritaki, Haritali, Harra, Harro, He li le, He Zi, Hirala, Indian Almond, Indian gall nut, Indian gallnut, Indian gall-nut, Ink nut, Jangalii harro, Kadukka, Kadukkai, Kadukkaya, Kalidruma, Karkchettu, Karshaphala, Manja lawai, Mirobalanos índicos, Mirobaran no ki, Myrobalan, Myrobolan Bellirique, Myrobolan Chébule, Myrobalanenbaum, Pathya, Rispiger, Terminalia arjuna, Terminalia bellirica, Terminalia chebula, Terminalia chebulic, Thuulo harro Tropical Almond, Vibhitaki.


Terminalia is a tree. Three species of terminalia are used for medicine. These species are Terminalia arjuna, Terminalia bellerica, and Terminalia chebula.

In traditional Ayurvedic medicine, Terminalia arjuna has been used to balance the three “humors”: kapha, pitta, and vata. It has also been used for asthma, bile duct disorders, scorpion stings, and poisonings.

The bark of Terminalia arjuna has been used in India for more than 3000 years, primarily as a heart remedy. An Indian physician named Vagbhata has been credited as the first to use this product for heart conditions in the seventh century A.D. Research on terminalia has been going on since the 1930s, but studies have provided mixed results. Its role, if any, in heart disease still remains uncertain.

Nevertheless, people today use Terminalia arjuna for disorders of the heart and blood vessels (cardiovascular disease), including heart disease and related chest pain, high blood pressure, and high cholesterol. It is also used as “a water pill,” and for earaches, dysentery, sexually transmitted diseases (STDs), diseases of the urinary tract, and to increase sexual desire.

Terminalia bellerica and Terminalia chebula are both used for high cholesterol and digestive disorders, including both diarrhea and constipation, and indigestion. They have also been used for HIV infection.

Terminalia bellerica is used to protect the liver and to treat respiratory conditions, including respiratory tract infections, cough, and sore throat.

Terminalia chebula is used for dysentery.

Terminalia bellerica and Terminalia chebula are used as a lotion for sore eyes.

Terminalia chebula is also used topically as a mouthwash and gargle.

Intravaginally, Terminalia chebula is used as a douche for treating vaginal infections.

In traditional Ayurvedic medicine, Terminalia bellerica has been used as a "health-harmonizer" in combination with Terminalia chebula and Emblica officinalis. This combination is also used to lower cholesterol and to prevent death of heart tissue.

How does it work?

Terminalia contains ingredients that help stimulate the heart. It might also help the heart by lowering cholesterol and blood pressure.


In the U.S., 1 in every 4 deaths is caused by heart disease. See Answer

Uses & Effectiveness

Possibly Effective for...

  • Chest pain (angina). Some research shows that taking Terminalia by mouth with conventional medications improves symptoms in people experiencing chest pain after a heart attack.
  • Congestive heart failure (CHF). Some research shows that taking Terminalia by mouth with conventional medications for 2 weeks improves symptoms in people with CHF.

Insufficient Evidence to Rate Effectiveness for...

  • Earaches.
  • HIV infection.
  • Lung conditions.
  • Severe diarrhea.
  • Urinary problems.
  • Water retention.
  • Other conditions.
More evidence is needed to rate the effectiveness of Terminalia for these uses.

Natural Medicines Comprehensive Database rates effectiveness based on scientific evidence according to the following scale: Effective, Likely Effective, Possibly Effective, Possibly Ineffective, Likely Ineffective, and Insufficient Evidence to Rate (detailed description of each of the ratings).

Side Effects

Terminalia arjuna is POSSIBLY SAFE when taken by mouth for 3 months or less. But don't use it without medical supervision. It might affect your heart..

Not enough is known about the safety of Terminalia bellerica and Terminalia chebula. It's best to avoid use until more is known.


See Images

Special Precautions & Warnings

Pregnancy: There is some evidence that Terminalia arjuna is POSSIBLY UNSAFE during pregnancy. The safety of the other two species during pregnancy is unknown. It's best to avoid using any terminalia species.

Breast-feeding: There is not enough reliable information about the safety of Terminalia if you are breast-feeding. Stay on the safe side and avoid use.

Diabetes: Terminalia might lower blood sugar levels. Your diabetes medications might need to be adjusted by your healthcare provider.

Surgery: Terminalia might decrease blood sugar levels and interfere with blood sugar control during surgery. Stop taking Terminalia at least 2 weeks before a scheduled surgery.


Medications for diabetes (Antidiabetes drugs)Interaction Rating: Moderate Be cautious with this combination.Talk with your health provider.

Terminalia might lower blood sugar. Diabetes medications are also used to lower blood sugar. Taking Terminalia along with diabetes medications might cause your blood sugar to go too low. But more evidence is needed to know if this interaction is a big concern. Monitor your blood sugar closely.

Some medications used for diabetes include glimepiride (Amaryl), glyburide (DiaBeta, Glynase PresTab, Micronase), insulin, pioglitazone (Actos), rosiglitazone (Avandia), chlorpropamide (Diabinese), glipizide (Glucotrol), tolbutamide (Orinase),


Heart Disease: Symptoms, Signs, and Causes See Slideshow


The following doses have been studied in scientific research:


  • For treating chest pain after a heart attack along with conventional treatments: 500 mg of the powdered bark of Terminalia arjuna every 8 hours daily.
  • For congestive heart failure: 500 mg of the powdered bark of Terminalia arjuna every 8 hours daily.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Ahirwar, B., Singhai, A. K., and Dixit, V. K. Effect of Terminalia chebula fruits on lipid profiles of rats. Journal of Natural Remedies 2003;3:31-35.

Ahmad, I., Mehmood, Z., and Mohammad, F. Screening of some Indian medicinal plants for their antimicrobial properties. J Ethnopharmacol. 1998;62(2):183-193. View abstract.

Ahn, M. J., Kim, C. Y., Lee, J. S., Kim, T. G., Kim, S. H., Lee, C. K., Lee, B. B., Shin, C. G., Huh, H., and Kim, J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis. Planta Med 2002;68(5):457-459. View abstract.

Amit, A., Saxena, V. S., Pratibha, N., D'Souza, P., Bagchi, M., Bagchi, D., and Stohs, S. J. Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis. Drugs Exp.Clin Res. 2003;29(3):107-115. View abstract.

Aqil, F., Khan, M. S., Owais, M., and Ahmad, I. Effect of certain bioactive plant extracts on clinical isolates of beta-lactamase producing methicillin resistant Staphylococcus aureus. J Basic Microbiol. 2005;45(2):106-114. View abstract.

Arora, S., Brits, E., Kaur, S., Kaur, K., Sohi, R. S., Kumar, S., and Verschaeve, L. Evaluation of genotoxicity of medicinal plant extracts by the comet and VITOTOX tests. J Environ.Pathol.Toxicol.Oncol 2005;24(3):193-200. View abstract.

Badmaev, V. and Nowakowski, M. Protection of epithelial cells against influenza A virus by a plant derived biological response modifier Ledretan-96. Phytother.Res 2000;14(4):245-249. View abstract.

Bhattacharya, S., Chaudhuri, S. R., Chattopadhyay, S., and Bandyopadhyay, S. K. Healing Properties of Some Indian Medicinal Plants against Indomethacin-Induced Gastric Ulceration of Rats. J Clin Biochem.Nutr 2007;41(2):106-114. View abstract.

Bonjar, G. H. Inhibition of Clotrimazole-resistant Candida albicans by plants used in Iranian folkloric medicine. Fitoterapia 2004;75(1):74-76. View abstract.

Carounanidy, U., Satyanarayanan, R., and Velmurugan, A. Use of an aqueous extract of Terminalia chebula as an anticaries agent: a clinical study. Indian J Dent.Res 2007;18(4):152-156. View abstract.

Cheng, H. Y., Lin, T. C., Yu, K. H., Yang, C. M., and Lin, C. C. Antioxidant and free radical scavenging activities of Terminalia chebula. Biol.Pharm.Bull. 2003;26(9):1331-1335. View abstract.

D'Souza, P., Amit, A., Saxena, V. S., Bagchi, D., Bagchi, M., and Stohs, S. J. Antioxidant properties of Aller-7, a novel polyherbal formulation for allergic rhinitis. Drugs Exp.Clin.Res. 2004;30(3):99-109. View abstract.

Deep, G., Dhiman, M., Rao, A. R., and Kale, R. K. Chemopreventive potential of Triphala (a composite Indian drug) on benzo(a)pyrene induced forestomach tumorigenesis in murine tumor model system. J Exp.Clin Cancer Res 2005;24(4):555-563. View abstract.

Dhanalakshmi, S., Devi, R. S., Srikumar, R., Manikandan, S., and Thangaraj, R. Protective effect of Triphala on cold stress-induced behavioral and biochemical abnormalities in rats. Yakugaku Zasshi 2007;127(11):1863-1867. View abstract.

Gandhi, N. M. and Nair, C. K. Radiation protection by Terminalia chebula: some mechanistic aspects. Mol.Cell Biochem. 2005;277(1-2):43-48. View abstract.

Gao, H., Huang, Y. N., Gao, B., and Kawabata, J. Chebulagic acid is a potent alpha-glucosidase inhibitor. Biosci.Biotechnol.Biochem. 2008;72(2):601-603. View abstract.

Grover, I. S. and Bala, S. Antimutagenic activity of Terminalia chebula (myroblan) in Salmonella typhimurium. Indian J Exp.Biol. 1992;30(4):339-341. View abstract.

Han, Q., Song, J., Qiao, C., Wong, L., and Xu, H. Preparative isolation of hydrolysable tannins chebulagic acid and chebulinic acid from Terminalia chebula by high-speed counter-current chromatography. J Sep.Sci 2006;29(11):1653-1657. View abstract.

Juang, L. J. and Sheu, S. J. Chemical identification of the sources of commercial Fructus Chebulae. Phytochem.Anal. 2005;16(4):246-251. View abstract.

Juang, L. J., Sheu, S. J., and Lin, T. C. Determination of hydrolyzable tannins in the fruit of Terminalia chebula Retz. by high-performance liquid chromatography and capillary electrophoresis. J Sep.Sci 2004;27(9):718-724. View abstract.

Kaur, S., Grover, I. S., Singh, M., and Kaur, S. Antimutagenicity of hydrolyzable tannins from Terminalia chebula in Salmonella typhimurium. Mutat.Res 11-9-1998;419(1-3):169-179. View abstract.

Kim, H. G., Cho, J. H., Jeong, E. Y., Lim, J. H., Lee, S. H., and Lee, H. S. Growth-inhibiting activity of active component isolated from Terminalia chebula fruits against intestinal bacteria. J Food Prot. 2006;69(9):2205-2209. View abstract.

Kumar, M. S., Kirubanandan, S., Sripriya, R., and Sehgal, P. K. Triphala promotes healing of infected full-thickness dermal wound. J Surg.Res. 2008;144(1):94-101. View abstract.

Lee, H. S., Jung, S. H., Yun, B. S., and Lee, K. W. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch.Toxicol. 2007;81(3):211-218. View abstract.

Lee, H. S., Won, N. H., Kim, K. H., Lee, H., Jun, W., and Lee, K. W. Antioxidant effects of aqueous extract of Terminalia chebula in vivo and in vitro. Biol.Pharm.Bull. 2005;28(9):1639-1644. View abstract.

Lee, S. H., Ryu, S. Y., Choi, S. U., Lee, C. O., and Ahn, J. W. Hydrolyzable tannins and related compound having cytotoxic activity from the fruits of Terminalia chebula. Archives of Pharmaceutical Research (Korea) 1995;18:118-120.

Lee, S. I., Hyun, P. M., Kim, S. H., Kim, K. S., Lee, S. K., Kim, B. S., Maeng, P. J., and Lim, J. S. Suppression of the onset and progression of collagen-induced arthritis by chebulagic acid screened from a natural product library. Arthritis Rheum. 2005;52(1):345-353. View abstract.

Malekzadeh, F., Ehsanifar, H., Shahamat, M., Levin, M., and Colwell, R. R. Antibacterial activity of black myrobalan (Terminalia chebula Retz) against Helicobacter pylori. Int.J Antimicrob.Agents 2001;18(1):85-88. View abstract.

Meena, A. K., Bansal, P., Kumar, S., Rao, M. M., and Garg, V. K. Estimation of heavy metals in commonly used medicinal plants: a market basket survey. Environ.Monit.Assess. 12-18-2009; View abstract.

Moeslinger, T., Friedl, R., Volf, I., Brunner, M., Koller, E., and Spieckermann, P. G. Inhibition of inducible nitric oxide synthesis by the herbal preparation Padma 28 in macrophage cell line. Can.J Physiol Pharmacol. 2000;78(11):861-866. View abstract.

Murali, Y. K., Anand, P., Tandon, V., Singh, R., Chandra, R., and Murthy, P. S. Long-term effects of Terminalia chebula Retz. on hyperglycemia and associated hyperlipidemia, tissue glycogen content and in vitro release of insulin in streptozotocin induced diabetic rats. Exp.Clin Endocrinol.Diabetes 2007;115(10):641-646. View abstract.

Na, M., Bae, K., Kang, S. S., Min, B. S., Yoo, J. K., Kamiryo, Y., Senoo, Y., Yokoo, S., and Miwa, N. Cytoprotective effect on oxidative stress and inhibitory effect on cellular aging of Terminalia chebula fruit. Phytother.Res 2004;18(9):737-741. View abstract.

Nadar, T. S. and Pillai, M. M. Effect of ayurvedic medicines on beta-glucuronidase activity of Brunner's glands during recovery from cysteamine induced duodenal ulcers in rats. Indian J Exp.Biol. 1989;27(11):959-962. View abstract.

Naik, G. H., Priyadarsini, K. I., Bhagirathi, R. G., Mishra, B., Mishra, K. P., Banavalikar, M. M., and Mohan, H. In vitro antioxidant studies and free radical reactions of triphala, an ayurvedic formulation and its constituents. Phytother.Res 2005;19(7):582-586. View abstract.

Naik, G. H., Priyadarsini, K. I., Naik, D. B., Gangabhagirathi, R., and Mohan, H. Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector. Phytomedicine. 2004;11(6):530-538. View abstract.

Naik, G. H., Priyadarsini, K. I., Satav, J. G., Banavalikar, M. M., Sohoni, D. P., Biyani, M. K., and Mohan, H. Comparative antioxidant activity of individual herbal components used in Ayurvedic medicine. Phytochemistry 2003;63(1):97-104. View abstract.

Parekh, J. and Chanda, S. Evaluation of antimicrobial activity of Terminalia chebula Retz. fruit in different solvents. Journal of Herbs, Spices, and Medicinal Plants 2007;13(2):107-116.

Patel, R. K., Gondaliya, D. P., and Subramanian, S. Evaluation of commercial "Haradae" (Terminalia chebula). Indian Journal of Natural Products (India) 2004;19:511-518.

Prasad, L., Husain, Khan T., Jahangir, T., and Sultana, S. Chemomodulatory effects of Terminalia chebula against nickel chloride induced oxidative stress and tumor promotion response in male Wistar rats. J Trace Elem.Med Biol. 2006;20(4):233-239. View abstract.

Prasad, L., Khan, T. H., Jahangir, T., and Sultana, S. Abrogation of DEN/Fe-NTA induced carcinogenic response, oxidative damage and subsequent cell proliferation response by Terminalia chebula in kidney of Wistar rats. Pharmazie 2007;62(10):790-797. View abstract.

Pratibha, N., Saxena, V. S., Amit, A., D'Souza, P., Bagchi, M., and Bagchi, D. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis. Int J Tissue React. 2004;26(1-2):43-51. View abstract.

Rani, P. and Khullar, N. Antimicrobial evaluation of some medicinal plants for their anti-enteric potential against multi-drug resistant Salmonella typhi. Phytother.Res 2004;18(8):670-673. View abstract.

Rao, N. K. and Nammi, S. Antidiabetic and renoprotective effects of the chloroform extract of Terminalia chebula Retz. seeds in streptozotocin-induced diabetic rats. BMC.Complement Altern.Med 2006;6:17. View abstract.

Sabu, M. C. and Kuttan, R. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol. 2002;81(2):155-160. View abstract.

Saleem, A., Ahotupa, M., and Pihlaja, K. Total phenolics concentration and antioxidant potential of extracts of medicinal plants of Pakistan. Z.Naturforsch.C. 2001;56(11-12):973-978. View abstract.

Saleem, A., Husheem, M., Harkonen, P., and Pihlaja, K. Inhibition of cancer cell growth by crude extract and the phenolics of Terminalia chebula retz. fruit. J Ethnopharmacol. 2002;81(3):327-336. View abstract.

Saravanan, S., Srikumar, R., Manikandan, S., Jeya, Parthasarathy N., and Sheela, Devi R. Hypolipidemic effect of triphala in experimentally induced hypercholesteremic rats. Yakugaku Zasshi 2007;127(2):385-388. View abstract.

Senthilkumar, G. P. and Subramanian, S. Evaluation of antioxidant potential of Terminalia chebula fruits studies in streptozotocin-induced diabetic rats. Pharmaceutical Biology (Netherlands) 2007;45:511-518.

Shin, T. Y., Jeong, H. J., Kim, D. K., Kim, S. H., Lee, J. K., Kim, D. K., Chae, B. S., Kim, J. H., Kang, H. W., Lee, C. M., Lee, K. C., Park, S. T., Lee, E. J., Lim, J. P., Kim, H. M., and Lee, Y. M. Inhibitory action of water soluble fraction of Terminalia chebula on systemic and local anaphylaxis. J Ethnopharmacol. 2001;74(2):133-140. View abstract.

Shivaprasad, H. N., Kharya, M. D., Rana, A. C, and Mohan, S. Preliminary immunodulatory activities of the aqueous extract of Terminalia chebula. Pharmaceutical Biology (Netherlands) 2006;44:32-34.

Sohni, Y. R. and Bhatt, R. M. Activity of a crude extract formulation in experimental hepatic amoebiasis and in immunomodulation studies. J Ethnopharmacol. 1996;54(2-3):119-124. View abstract.

Srikumar, R., Jeya, Parthasarathy N., and Sheela, Devi R. Immunomodulatory activity of triphala on neutrophil functions. Biol.Pharm.Bull. 2005;28(8):1398-1403. View abstract.

Srikumar, R., Parthasarathy, N. J., Manikandan, S., Narayanan, G. S., and Sheeladevi, R. Effect of Triphala on oxidative stress and on cell-mediated immune response against noise stress in rats. Mol.Cell Biochem. 2006;283(1-2):67-74. View abstract.

Srikumar, R., Parthasarathy, N. J., Shankar, E. M., Manikandan, S., Vijayakumar, R., Thangaraj, R., Vijayananth, K., Sheeladevi, R., and Rao, U. A. Evaluation of the growth inhibitory activities of Triphala against common bacterial isolates from HIV infected patients. Phytother.Res. 2007;21(5):476-480. View abstract.

Suchalatha, S. and Shyamala Devi, C. S. Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol. Indian J Exp.Biol. 2004;42(2):174-178. View abstract.

Suguna, L., Singh, S., Sivakumar, P., Sampath, P., and Chandrakasan, G. Influence of Terminalia chebula on dermal wound healing in rats. Phytother.Res 2002;16(3):227-231. View abstract.

Suryadevara, P., Mithravinda, Mohan, Y. S., Choudhury, R., and Reddy, M. Antimicrobial potency and synergistic activity of aqueous extracts of Emblica officinalis and Terminalia chebula (MAPS-P-411). International Pharmaceutical Federation World Congress 2002;62:134.

Tamhane, M. D., Thorat, S. P., Rege, N. N., and Dahanukar, S. A. Effect of oral administration of Terminalia chebula on gastric emptying: an experimental study. J Postgrad.Med 1997;43(1):12-13. View abstract.

Tasaduq, S. A., Singh, K., Sethi, S., Sharma, S. C., Bedi, K. L., Singh, J., Jaggi, B. S., and Johri, R. K. Hepatocurative and antioxidant profile of HP-1, a polyherbal phytomedicine. Hum Exp.Toxicol. 2003;22(12):639-645. View abstract.

Tasduq, S. A., Singh, K., Satti, N. K., Gupta, D. K., Suri, K. A., and Johri, R. K. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination. Hum Exp.Toxicol. 2006;25(3):111-118. View abstract.

Vonshak, A., Barazani, O., Sathiyamoorthy, P., Shalev, R., Vardy, D., and Golan-Goldhirsh, A. Screening South Indian medicinal plants for antifungal activity against cutaneous pathogens. Phytother.Res 2003;17(9):1123-1125. View abstract.

Zhang, X., Chen, C., He, S., and Ge, F. [Supercritical-CO2 fluid extraction of the fatty oil in Terminalia chebula and GC-MS analysis]. Zhong.Yao Cai. 1997;20(9):463-464. View abstract.

Anand KK, Singh B, Saxena AK, et al. 3,4,5-Trihydroxy benzoic acid (gallic acid), the hepatoprotective principle in the fruits of Terminalia belerica-bioassay guided activity. Pharmacol Res 1997;36:315-21. View abstract.

Arseculeratne SN, Gunatilaka AA, Panabokke RG. Studies of medicinal plants of Sri Lanka. Part 14: Toxicity of some traditional medicinal herbs. J Ethnopharmacol 1985;13:323-35. View abstract.

Bajpai M, Pande A, Tewari SK, Prakash D. Phenolic contents and antioxidant activity of some food and medicinal plants. Int J Food Sci Nutr 2005;56:287-91. View abstract.

Bharani A, Ganguly A, Bhargava KD. Salutary effect of Terminalia Arjuna in patients with severe refractory heart failure. Int J Cardiol 1995;49:191-9. View abstract.

Chevallier A. Encyclopedia of Medicinal Plants. New York, NY: DK Publishing, 1996.

Dwivedi S, Agarwal MP. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease. J Assoc Physicians India 1994;42:287-9. View abstract.

Dwivedi S, Jauhari R. Beneficial effects of Terminalia arjuna in coronary artery disease. Indian Heart J 1997;49:507-10. View abstract.

el-Mekkawy S, Meselhy MR, Kusumoto IT, et al. Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem Pharm Bull (Tokyo) 1995;43:641-8. View abstract.

Hamada S, Kataoka T, Woo JT, et al. Immunosuppressive effects of gallic acid and chebulagic acid on CTL-mediated cytotoxicity. Biol Pharm Bull 1997;20:1017-9. View abstract.

Jagtap AG, Karkera SG. Potential of the aqueous extract of Terminalia chebula as an anticaries agent. J Ethnopharmacol 1999;68:299-306. View abstract.

Kurokawa M, Nagasaka K, Hirabayashi T, et al. Efficacy of traditional herbal medicines in combination with acyclovir against herpes simplex virus type 1 infection in vitro and in vivo. Antiviral Res 1995;27:19-37. View abstract.

Pettit GR, Hoard MS, Doubek DL, et al. Antineoplastic agents 338. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). J Ethnopharmacol 1996;53:57-63. View abstract.

Phadke SA, Kulkarni SD. Screening of in vitro antibacterial activity of Terminalia chebula, Eclapta alba and Ocimum sanctum. Indian J Med Sci 1989;43:113-7. View abstract.

Ram A, Lauria P, Gupta R, et al. Hypocholesterolaemic effects of Terminalia arjuna tree bark. J Ethnopharmacol 1997;55:165-9. View abstract.

Sato Y, Oketani H, Singyouchi K, et al. Extraction and purification of effective antimicrobial constituents of Terminalia chebula RETS. against methicillin-resistant Staphylococcus aureus. Biol Pharm Bull 1997;20:401-4. View abstract.

Shaila HP, Udupa SL, Udupa AL. Hypolipidemic activity of three indigenous drugs in experimentally induced atherosclerosis. Int J Cardiol 1998;67:119-214. View abstract.

Shiraki K, Yukawa T, Kurokawa M, Kageyama S. [Cytomegalovirus infection and its possible treatment with herbal medicines]. Nippon Rinsho 1998;56:156-60. View abstract.

Suthienkul O, Miyazaki O, Chulasiri M, et al. Retroviral reverse transcriptase inhibitory activity in Thai herbs and spices: screening with Moloney murine leukemia viral enzyme. Southeast Asian J Trop Med Public Health 1993;24:751-5. View abstract.

Thakur CP, Thakur B, Singh S, et al. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol-induced atherosclerosis in rabbits. Int J Cardiol 1988;21:167-75. View abstract.

Yukawa TA, Kurokawa M, Sato H, et al. Prophylactic treatment of cytomegalovirus infection with traditional herbs. Antiviral Res 1996;32:63-70. View abstract.

Health Solutions From Our Sponsors